Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

A trial in patients with ABCA4 mutation-associated retinal dystrophy. Pending

2024-520425-37-00 Biallelic ABCA4 Mutation-Associated Retinal Dystrophy. 7
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio… Pending

2025-523704-77-00 Geographic atrophy secondary to age-related macular deg 4
Randomized clinical trial to evaluate the use of PRGF eye drops in patients with dry eye disease Pending

2023-507357-15-01 Dry Eye Disease 6
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants Pending

2025-521713-57-00 Noninfectious Uveitis 7
The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy Pending

2025-521163-12-01 Graves' Orbitopathy 9
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants Pending

2025-521758-40-00 Geographic Atrophy 1
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma Pending

2025-524953-15-00 Uveal melanoma 3
A clinical trial to assess the efficacy and safety of ADX-308, a new type of treatment for Geographic Atrophy (GA), an advanced stage of eye… Pending

2025-521779-30-00 Geographic atrophy secondary to age-related macular deg 4
CHOPIN Pending

2024-516127-14-01 metastasized melonama uveal 7
Evaluation of the regenerative efficacy of Endoret® (PRGF-Plasm Rich in Growth Factors) on the ocular surface of glaucoma patients treated c… Pending

2025-520642-29-00 glaucoma 4
An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease Pending

2025-522460-33-00 Stargardt Disease 5
Selective laser trabeculoplasty versus eye drops for first line treatment of exfoliation ocular hypertension or glaucoma: a randomised clini… Pending

2024-520083-33-00 Glaucoma 6
A clinical study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SB-007 in Subjects with Stargardt Disease. Pending

2024-519535-42-00 Stargardt Disease 7
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion (NEXUS) Pending

2026-525349-65-00 Diabetic Retinopathy 4
A Study for Comparing a Generic Combination of Brimonidine and Timolol Eye Drops versus Combigan® Eye Drops in the Treatment of Patients wit… Pending

2025-523227-22-00 Ocular Hypertension 5
Clinical trial to evaluate the genetic polymorphisms influence in the response to Ranibizumab and Bevacizumab treatment in patients with Age… Pending

2024-518990-33-00 Age-Associated Macular Degeneration 11
Evaluation of Tildrakizumab in the Treatment of Ocular Sequelae in Lyell syndrome Pending

2025-522556-10-01 Ocular Sequelae in Lyell syndrome 4
An Open-label, Rollover Study to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease Pending

2025-523280-38-00 Thyroid Eye Disease 4
CellThRPE1 Pending

2024-517546-33-00 Geographic atrophy secondary to dry age-related macular 1
OLISENS-ANIRIDIA Pending

2025-522609-39-00 Corneal Neovascularization in Aniridia-associated Kerat 4
Study to Assess K1-70 in Participants with Active Thyroid Eye Disease Recruiting

2024-519292-26-00 Graves’ disease and active thyroid eye disease 4 2026-05-28
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
Two initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD Recruiting

2025-523478-17-00 Neovascular age-related macular degeneration 6 2026-03-03
A phase 2, double-masked, randomized, multicenter, parallel group, placebo-controlled study to investigate the efficacy and safety of GAL-10… Recruiting

2024-519128-26-00 Non-foveal geographic atrophy secondary to non-neovascu 4 2025-05-22